1. EP294/#883 Elimusertib, an oral ataxia telangiectasia and RAD3-related inhibitor, in advanced gynecologic cancers with DNA damage response defects. (4th December 2022) Authors: Tan, David S; Castonguay, Vincent; Cote, Gregory; Bono, Johann S De; El-Rayes, Bassel; Gabrail, Nashat; Iwasa, Satoru; Joerger, Markus; Jones, Robert; Sawyer, Michael B; Shapiro, Geoffrey I; Tan, Daniel; Merz, Claudia; Uttenreuther, Regina; Jeffers, Michael; Ferraldeschi, Roberta; Sharma, Neelesh... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗